Nextseq reagent kits
Ended Awarded
- Contract number
- HHSF22301039T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $59,244
Award facts
- Contract value 100% obligated
- $59,243.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration (FDA) awarded a delivery order contract to Illumina, Inc. for NextSeq reagent kits with a ceiling value of $59,243.80. Executed on May 18, 2016, with an ultimate completion date of September 13, 2017, this firm fixed-price delivery order utilized no set-aside designation and reflects Illumina's specialized capabilities in genomic sequencing consumables. The contract was performed at Illumina's San Diego, California location, where the company manufactures advanced DNA and RNA sequencing reagents and related products. NextSeq reagent kits are consumable products essential for nucleic acid sequencing operations, supporting the FDA's scientific research and analytical capabilities.
Illumina, Inc. is a leading biotechnology manufacturer headquartered in San Diego, specializing in genetic sequencing and genomic analysis technologies. The company serves multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, Department of Veterans Affairs, and the FDA, supplying advanced sequencing systems, reagent kits, and bioinformatics software. This delivery order represents a targeted procurement of specialized sequencing consumables that support the FDA's mission in areas including pharmaceutical analysis, diagnostic development, and related scientific research initiatives requiring genomic sequencing capabilities.
Quick answers
Who was awarded contract HHSF22301039T?
HHSF22301039T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on May 18, 2016.
How much is contract HHSF22301039T worth?
The government has obligated $59,244 on HHSF22301039T.
Is contract HHSF22301039T an order under another contract?
Yes. HHSF22301039T is a delivery order under HHSF223201210031I, an indefinite delivery contract.
Was contract HHSF22301039T competed?
The extent of competition for HHSF22301039T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award